Each year, new positions open on ASCO’s Board of Directors
(including President-Elect) and on the ASCO Nominating Committee. In
the following interview, Nominating Committee Chair Howard A.
“Skip” Burris III, MD, shares his insights on the
process with ASCO Connection
Voting will open on Monday, October 15, 2012, at 12:00 PM (Eastern);
the voting period closes on November 20, 2012, at 11:59 PM (Eastern).
when voting opens for detailed information on
all candidates. Voting-eligible members can access the secure
electronic proxy ballot using their ASCO.org username and password.
Election results will be announced in December 2012.
How does the Nominating
Committee develop the slate of
Committee accumulates names year-round from a variety of sources. We
encourage members to submit names, and we also receive many candidate
suggestions from current and recent ASCO Board members.
For the first time, members could submit nominations until just after
the close of the 2012 ASCO Annual Meeting. Throughout the Meeting,
people came up to me with suggestions of names or handed me pieces of
paper to nominate colleagues, and other members of the Nominating
Committee had the same experience. Almost every time I walked across
McCormick Place, I would be stopped multiple times by members who
wanted to recommend someone who they thought would be a great
candidate. It speaks to how important it is for members of the
Nominating Committee to be active and visible during the Meeting and
throughout the year.
This year is my third on the Nominating Committee, and this was the
largest and most diverse pool of candidates we’ve considered
in developing the slate.
What characteristics did the Nominating Committee consider, or what
niches did you look to fill?
With the burgeoning
interest in electronic health records and electronic communication, we
looked for members with an interest, affinity, or expertise in the area
of information technology. Widely discussed among the Nominating
Committee was appropriate community practice representation.
We’ve presented a slate of community oncologists from
different parts of the country, with expertise in different practice
sizes and practice backgrounds—the common thread is proven
leadership skills. The third area we were careful to consider was
international diversity, bringing representation to the Board from
parts of the world not typically represented. We also looked at disease
representation to ensure that candidates came from a spectrum of
disease specialties. Our goal was to present a slate that represented
the same level of diversity you find in ASCO’s membership.
Why should members cast their votes in the election?
often don’t consider is that ASCO Board members serve three
to four years, and that Board is interacting not only within ASCO, but
with organizations across the country and around the world.
It’s important that members have a say in their
representation to give the Board a clear mandate and a show of
Burris is the Chief Medical Officer and Executive Director of the Drug
Development Program at Sarah Cannon Research Institute and a partner at
Tennessee Oncology. An ASCO member since 1991, he has served on the
of Clinical Oncology Editorial Board, the
Cancer Education Committee, and the Board of Directors, among others.
He has been a Fellow of the American Society of Clinical Oncology since